Flo Health in a $50M series B financing co-led by VNV Global and Target Global.

Flo Health, a London, UK-based business based on an OB-GYN-recommended app for period and cycle tracking, announced completing a $50M series B financing round.

The money was raised from investors co-led by VNV Global and Target Global.

Flo Health, founded in 2016 by Andrew Kovzel, Dmitry Gurski, Max Scrobov and Yuri Gurski, developed a mobile application that supports women at every stage of their reproductive cycle. It provides curated cycle tracking and predictions, personalized health insights, and real-time health alerts based on tracked symptoms in an easy-to-use interface.

The company says it built a community of over 200 million users, with 1.5M MAU in August 2021. Flo’s business model is purely subscription-based. The company recently introduced Flo as a benefit to US employers to better support women in the workplace with the resources they need to thrive — physically and mentally.